Vaccines
A recent review study suggests that the development of certain antivirals and gene therapy are likely to progress quickest in the fight against dangerous coronviruses such as SARS-CoV-2
| 3 min read
Professors argue that many of the deficiencies in the way medical research is conducted under normal circumstances seem to be amplified in this pandemic
| 2 min read
BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines, and diagnostic biomarkers
| 2 min read
HALIX Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine
| 2 min read
Because of the urgency to get new tests, therapies, and preventions into the clinic amid a pandemic, many of these approaches are undergoing a trial by fire
| 1 min read
Live dashboard offers an overview of all the trials taking place in the international effort to tackle the pandemic
| 3 min read
The vaccine uses a harmless virus to deliver a MERS coronavirus protein into cells to generate an immune response
| 2 min read
OXGENE and The Native Antigen Company are developing an improved, scalable approach to SARS-CoV-2 antigen manufacture
| 2 min read
To speed the pace of research, Data Expedition, Inc. offers software at no charge to move datasets quickly and reliably between hospitals, labs, and research institutes
| 2 min read
Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks, and buffy coats for COVID-19, cell, and gene therapy research within hours of collection
| 3 min read
